The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 participants ...

Here’s what to know about the updated vaccines. How are the new Covid vaccines different? The new shots from Pfizer and Moderna are designed to target the KP.2 strain, a descendant of the highly ...

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday.

Moderna Inc. said its COVID-19 vaccine remained 93% effective six months after the second shot as it reported second-quarter earnings and revenue that beat expectations.

Moderna early data shows coronavirus vaccine is nearly 95% effective 03:57. For the second time this month, there's promising news from a COVID-19 vaccine candidate.

With the pandemic cutting an ever-broadening swath through the country, Moderna’s announcement that preliminary data indicate its COVID-19 vaccine was 95% effective offered Americans a much ...

Moderna’s Covid Vaccine: What You Need to Know. By Carl Zimmer and Denise Grady. Published Nov. 16, 2020 Updated Nov. 30, 2020. Share full article. Image.

COVID-19 vaccine: Moderna is set to begin its phase 3 clinical trial on a coronavirus vaccine. It's the first phase 3 trial in the U.S.